Carolina Schencke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Carolina Schencke has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Cristian Sandoval
Carrera de Terapia Ocupacional, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Temuco 4810101, Chile
1 shared publication - Francisca Acevedo
Center of Excellence in Translational Medicine (CEMT), and Scientific and Technological Bioresource Nucleus (BIOREN), Faculty of Medicine, Universidad de La Frontera, Avenida Francisco Salazar 1145, Temuco 4780000, Chile
1 shared publication - Jessica Salvo
Escuela de Enfermería, Facultad de Salud, Universidad Santo Tomás, Temuco, Chile
1 shared publication - Mariano del Sol
Centro de Excelencia en Estudios Morfológicos y Quirúrgicos, Universidad de La Frontera, Temuco 4811230, Chile
1 shared publication
Latest Publications
- Open Access
- 24 August 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (9) , 2187
Healing Effect of a Nano-Functionalized Medical-Grade Honey for the Treatment of Infected Wounds
Based on the qualities of Ulmo honey (Eucryphia cordifolia), a medical-grade honey (Ulmoplus®) has been developed. Relevant to this, the use of copper represents an emerging therapy for the treatment of wounds. Therefore, the aim of this study was to see how this medical-grade honey with copper nanoparticles (CuNPs) helped to heal infected or non-infected wounds. Twenty-four guinea pigs (Cavia porcellus) were divided into four groups for phase 1 (without and with infection, U + F1 and U + F2), and two groups for phase 2 (selected formulation, without and with infection, U + F2NI and U + F2I). Bacteriological and histopathological studies, collagen fibers content evaluation, and stereological analysis were performed. The selected formulation displayed the same antibacterial potency as Ulmoplus®, indicating that this medical-grade honey by itself can be used as an antibacterial agent. However, the evaluation of collagen content demonstrated a significant increase in fibroblast and type III collagen fibers for infected and uninfected groups, which correlated with the histopathological study. Therefore, it is correct to affirm that adding CuNPs to Ulmoplus® improved the maturation of collagen fibers. Finally, polymorphonuclear cells presented similar values between experimental groups, which would indicate that the formulation under study was able to regulate the inflammatory process despite their infectious condition.
- 24 August 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (9) , 2187
Open AccessHealing Effect of a Nano-Functionalized Medical-Grade Honey for the Treatment of Infected Wounds
Based on the qualities of Ulmo honey (Eucryphia cordifolia), a medical-grade honey (Ulmoplus®) has been developed. Relevant to this, the use of copper represents an emerging therapy for the treatment of wounds. Therefore, the aim of this study was to see how this medical-grade honey with copper nanoparticles (CuNPs) helped to heal infected or non-infected wounds. Twenty-four guinea pigs (Cavia porcellus) were divided into four groups for phase 1 (without and with infection, U + F1 and U + F2), and two groups for phase 2 (selected formulation, without and with infection, U + F2NI and U + F2I). Bacteriological and histopathological studies, collagen fibers content evaluation, and stereological analysis were performed. The selected formulation displayed the same antibacterial potency as Ulmoplus®, indicating that this medical-grade honey by itself can be used as an antibacterial agent. However, the evaluation of collagen content demonstrated a significant increase in fibroblast and type III collagen fibers for infected and uninfected groups, which correlated with the histopathological study. Therefore, it is correct to affirm that adding CuNPs to Ulmoplus® improved the maturation of collagen fibers. Finally, polymorphonuclear cells presented similar values between experimental groups, which would indicate that the formulation under study was able to regulate the inflammatory process despite their infectious condition.